Suppr超能文献

基于蛋白质组学的慢性疼痛系统生物学。

Proteome-based systems biology in chronic pain.

机构信息

Max Planck Institute of Experimental Medicine, Somatosensory Signaling and Systems Biology Group, 37075 Goettingen, Germany.

Max Planck Institute of Experimental Medicine, Somatosensory Signaling and Systems Biology Group, 37075 Goettingen, Germany.

出版信息

J Proteomics. 2019 Jan 6;190:1-11. doi: 10.1016/j.jprot.2018.04.004. Epub 2018 Apr 10.

Abstract

Chronic pain represents a major medical challenge in the 21 century. Enormous efforts have been invested towards deciphering the complexity of chronic pain from different angles (molecular, physiological, psychosocial, and behavioral) in both preclinical and clinical settings. While progress has been made, our understanding of the underlying mechanisms of chronic pain remains insufficient. Consequently, chronic pain treatment is often inadequate. It lacks efficacy in most patients and is associated with detrimental side effects - a situation which calls for urgent changes in pain research and management. In this review we propose that protein-centric systems biology can significantly contribute to pain research. This approach may introduce the long-awaited paradigm shift in pain research from single targets to multidimensional cellular networks. We critically discuss how recent advances in reproducible and comprehensive proteome profiling can be exploited by pain researchers in the following ways: to gain mechanistic insights into chronic pain and its diverse forms, to facilitate clinical trials and the search for new drug targets, and to objectively assess chronic pain and its stages in individual patients by defining so-called protein disease signatures (PDS). We feel that the integration of proteomics into the toolbox of pain researchers and physicians alike will open new avenues towards a better understanding and management of chronic pain. SIGNIFICANCE STATEMENT: The immense challenges associated with chronic pain call for urgent changes in pain research and management. Here, we highlight the enormous potential of a proteome-based systems biology approach for advancing our understanding of chronic pain from a mechanistic, translational and clinical angle.

摘要

慢性疼痛是 21 世纪的主要医学挑战。为了解决这一问题,研究人员从分子、生理、心理社会和行为等多个角度,在临床前和临床环境中对慢性疼痛的复杂性进行了大量研究。虽然已经取得了一定的进展,但我们对慢性疼痛的潜在机制的理解仍然不足。因此,慢性疼痛的治疗往往不够充分。它在大多数患者中效果不佳,而且伴随着有害的副作用——这种情况迫切需要改变疼痛研究和管理的方式。在这篇综述中,我们提出以蛋白质为中心的系统生物学可以为疼痛研究做出重大贡献。这种方法可能会将疼痛研究从单一靶点向多维细胞网络的范式转变。我们批判性地讨论了疼痛研究人员如何利用最近在可重现和全面的蛋白质组谱分析方面的进展,从以下几个方面来深入了解慢性疼痛及其多种形式:促进慢性疼痛及其不同形式的机制研究、促进临床试验和新药物靶点的寻找、通过定义所谓的蛋白质疾病特征(PDS)来客观评估慢性疼痛及其在个体患者中的阶段。我们认为,将蛋白质组学纳入疼痛研究人员和医生的工具包中,将为更好地理解和管理慢性疼痛开辟新的途径。

重要声明:慢性疼痛带来的巨大挑战需要对疼痛研究和管理进行紧急改变。在这里,我们从机制、转化和临床角度强调了基于蛋白质组的系统生物学方法在深入了解慢性疼痛方面的巨大潜力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验